Quality of life after curative or palliative surgical treatment of pancreatic and periampullary carcinoma

Quality of life (QOL) is an important outcome measure after treatment of pancreatic and periampullary carcinoma. The aim of this prospective longitudinal study was to analyse QOL after surgery for resectable pancreatic or periampullary carcinoma.

[1]  H. Jeekel.  Prognostic factors following curative resection for pancreatic adenocarcinoma. , 2004, Annals of surgery.

[2]  Robert E Harbaugh,et al.  Surgeon Volume and Operative Mortality in the United States. , 2004, Neurosurgery.

[3]  R. Stephens,et al.  Approaches to the analysis of quality of life data: experiences gained from a Medical Research Council Lung Cancer Working Party palliative chemotherapy trial , 1994, Quality of Life Research.

[4]  Dirk J Gouma,et al.  The Need for a Prophylactic Gastrojejunostomy for Unresectable Periampullary Cancer: A Prospective Randomized Multicenter Trial With Special Focus on Assessment of Quality of Life , 2003, Annals of surgery.

[5]  C. Earle,et al.  Prognostic Factors Following Curative Resection for Pancreatic Adenocarcinoma: A Population-Based, Linked Database Analysis of 396 Patients , 2003, Annals of surgery.

[6]  Patrick M M Bossuyt,et al.  Laparoscopic Staging and Subsequent Palliation in Patients With Peripancreatic Carcinoma , 2003, Annals of surgery.

[7]  S. Cha,et al.  Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  J. Sloan.  Asking the obvious questions regarding patient burden. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  T. Ohtsuka,et al.  Quality of life after pylorus-preserving pancreatoduodenectomy. , 2001, American journal of surgery.

[10]  T. V. van Gulik,et al.  Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update. , 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[11]  D. Gouma,et al.  Rates of Complications and Death After Pancreaticoduodenectomy: Risk Factors and the Impact of Hospital Volume , 2000, Annals of surgery.

[12]  K. Lillemoe,et al.  Resected adenocarcinoma of the pancreas— 616 patients: Results, outcomes, and prognostic indicators , 2000, Journal of Gastrointestinal Surgery.

[13]  K. Lillemoe,et al.  Quality of life and outcomes after pancreaticoduodenectomy. , 2000, Annals of surgery.

[14]  R. McLeod,et al.  Biliary stenting versus bypass surgery for the palliation of malignant distal bile duct obstruction: A meta‐analysis , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[15]  J. Donovan,et al.  A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma , 2000, Cancer.

[16]  D. Gouma,et al.  Validation of the gastrointestinal quality of life index for patients with potentially operable periampullary carcinoma , 2000, The British journal of surgery.

[17]  Taylor Murray,et al.  Cancer statistics, 2000 , 2000, CA: a cancer journal for clinicians.

[18]  K. Lillemoe,et al.  Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. , 1999, Annals of surgery.

[19]  D. Gouma,et al.  UvA-DARE ( Digital Academic Repository ) Are there indications for palliative resection in pancreatic cancer ? , 1999 .

[20]  S. Pedrazzoli,et al.  Current Views on Surgical Treatment of Pancreatic Cancer , 1999, Digestive Surgery.

[21]  R. Steele,et al.  Measurement of quality of life in surgery. , 1999, Journal of the Royal College of Surgeons of Edinburgh.

[22]  M. Sprangers,et al.  Revealing response shift in longitudinal research on fatigue--the use of the thentest approach. , 1999, Acta oncologica.

[23]  B. Gudjonsson.  Periampullary adenocarcinoma: analysis of 5-year survivors. , 1999, Annals of surgery.

[24]  M. Sprangers,et al.  Innovations and dilemmas in psychosocial oncology. Contributions from the 10th conference of the European Society for Psychosocial Oncology. , 1999, Acta oncologica.

[25]  J. Müller,et al.  Quality of life after surgical treatment of gastric carcinoma. , 2003, The European journal of surgery = Acta chirurgica.

[26]  T. V. van Gulik,et al.  Outcome of palliative biliary and gastric bypass surgery for pancreatic head carcinoma in 126 patients , 1997, The British journal of surgery.

[27]  K. Lillemoe,et al.  Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer? , 1996, Annals of surgery.

[28]  B. Gudjonsson.  Carcinoma of the pancreas: critical analysis of costs, results of resections, and the need for standardized reporting. , 1995, Journal of the American College of Surgeons.

[29]  J. Williams,et al.  Gastrointestinal Quality of Life Index: Development, validation and application of a new instrument , 1995, The British journal of surgery.

[30]  R. McLeod,et al.  Quality of life, nutritional status, and gastrointestinal hormone profile following the Whipple procedure. , 1995, American journal of surgery.

[31]  S Greenfield,et al.  The Importance of Co-existent Disease in the Occurrence of Postoperative Complications and One-Year Recovery in Patients Undergoing Total Hip Replacement: Comorbidity and Outcomes After Hip Replacement , 1993, Medical care.

[32]  S. Fraser.  Quality‐of‐life measurement in surgical practice , 1993, The British journal of surgery.

[33]  J. de Haes,et al.  Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. , 1990, British Journal of Cancer.

[34]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[35]  A. Stewart,et al.  The MOS short-form general health survey. Reliability and validity in a patient population. , 1988, Medical care.

[36]  J. Morris,et al.  Quality of life of cancer patients at different stages in the disease trajectory. , 1987, Journal of chronic diseases.

[37]  J. Morris,et al.  Last days: a study of the quality of life of terminally ill cancer patients. , 1986, Journal of chronic diseases.

[38]  D. Karnofsky,et al.  The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma , 1948 .